- Home
- CMPX vs ABSI Comparison
CMPX vs ABSI Comparison
Compare CMPX & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- ABSI
- Stock Information
- Founded
- CMPX 2014
- ABSI 2011
- Country
- CMPX United States
- ABSI United States
- Employees
- CMPX N/A
- ABSI N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- CMPX Health Care
- ABSI Health Care
- Exchange
- CMPX Nasdaq
- ABSI Nasdaq
- Market Cap
- CMPX 291.8M
- ABSI 338.0M
- IPO Year
- CMPX N/A
- ABSI 2021
- Fundamental
- Price
- CMPX $2.61
- ABSI $2.59
- Analyst Decision
- CMPX Strong Buy
- ABSI Strong Buy
- Analyst Count
- CMPX 9
- ABSI 5
- Target Price
- CMPX $12.67
- ABSI $8.40
- AVG Volume (30 Days)
- CMPX 946.0K
- ABSI 3.8M
- Earning Date
- CMPX 08-11-2025
- ABSI 08-13-2025
- Dividend Yield
- CMPX N/A
- ABSI N/A
- EPS Growth
- CMPX N/A
- ABSI N/A
- EPS
- CMPX N/A
- ABSI N/A
- Revenue
- CMPX $850,000.00
- ABSI $4,815,000.00
- Revenue This Year
- CMPX N/A
- ABSI $81.76
- Revenue Next Year
- CMPX N/A
- ABSI $287.79
- P/E Ratio
- CMPX N/A
- ABSI N/A
- Revenue Growth
- CMPX N/A
- ABSI N/A
- 52 Week Low
- CMPX $0.77
- ABSI $2.01
- 52 Week High
- CMPX $4.08
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- CMPX 60.92
- ABSI 38.62
- Support Level
- CMPX $2.52
- ABSI $2.64
- Resistance Level
- CMPX $2.71
- ABSI $2.86
- Average True Range (ATR)
- CMPX 0.17
- ABSI 0.17
- MACD
- CMPX 0.00
- ABSI -0.03
- Stochastic Oscillator
- CMPX 68.64
- ABSI 15.87
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.